Hjemmelegene
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | 1.9m | 4.0m | 2.2m | 2.5m |
| % growth | - | 564 % | 118 % | 291 % | 115 % | (46 %) | 16 % |
| EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | (1.1m) | (4.8m) | - |
| % EBITDA margin | (539 %) | (138 %) | (141 %) | (19 %) | (28 %) | (216 %) | - |
| Profit | (<1m) | (<1m) | (<1m) | (<1m) | (1.3m) | (4.9m) | - |
| % profit margin | (571 %) | (160 %) | (156 %) | (24 %) | (31 %) | (223 %) | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | NOK5.5m | Seed | |
NOK10.0m | Early VC | ||
NOK1.5m | Grant | ||
NOK15.0m | Early VC | ||
* | NOK70.0m | Early VC | |
* | N/A | Early VC | |
| Total Funding | $12.3m | ||
Recent News about Hjemmelegene
EditHjemmelegene operates in the healthcare sector, offering on-demand house call services by licensed and certified doctors. The company serves a wide range of clients, from infants to the elderly, providing medical care directly in the comfort of their homes. This service is particularly beneficial for those who prefer to avoid waiting times and travel to medical facilities. Hjemmelegene's business model is based on a fixed pricing structure, charging NOK 1290 per visit, which includes consultations during days, evenings, and weekends. The company ensures that all doctors are handpicked, certified in Norway, and fluent in English, ensuring high-quality care for a diverse patient base. By leveraging a user-friendly online platform, clients can easily schedule appointments at their convenience, making healthcare more accessible and efficient.
Keywords: house call doctors, on-demand healthcare, fixed price, certified physicians, family medicine, convenient medical care, home visits, patient-centric, Norwegian healthcare, online scheduling.